News
Examining the Future: Quest Diagnostics's Earnings Outlook
Return on Equity (ROE): Quest Diagnostics's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 3.24%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Quest Diagnostics: Q1 Earnings Snapshot
Quest Diagnostics expects full-year earnings in the range of $9.55 to $9.80 per share, with revenue in the range of $10.7 billion to $10.85 billion. This story was generated by Automated Insights ( http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DGX at https://www.zacks.com/ap/DGX
StockStory.org on MSN21h
Quest (NYSE:DGX) Beats Q1 Sales TargetsHealthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q1 CY2025 results , with sales up 12.1% year on year to ...
Quest Diagnostics (DGX) reports 12% Q1 2025 revenue growth, driven by acquisitions, partnerships, and advanced diagnostics.
Despite Quest Diagnostics’ strong performance, analysts remain cautiously optimistic about its prospects. The stock has a consensus rating of “Moderate Buy” from the 16 analysts covering the ...
Quest's robust performance, alongside its collaboration ... or dementia. Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ...
Shares of Quest Diagnostics Inc. DGX slid 2.74% to $159.80 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.57% to ...
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...
Quest Diagnostics Inc.’s DGX investments in Advanced ... A strong focus on operational excellence is highly encouraging for the stock. Meanwhile, unfavorable solvency and a fierce competitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback